Stockreport

Bellicum up 9% premarket on BPX-601 data [Seeking Alpha]

Bellicum Pharmaceuticals, Inc.  (BLCM) 
Last bellicum pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview
PDF Bellicum Pharmaceuticals (NASDAQ: BLCM 9% Phase 1 translational data Data from cohort 5B showed enhanced survival and persistence up to nine months. Activation of BPX-60 [Read more]